JP Morgan Chase
KZIA

JP Morgan Chase’s Kazia Therapeutics KZIA Stock Holding History

JP Morgan Chase’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Buy
+2,863
New +$34.9K ﹤0.01% 6499
2025
Q1 		– Sell
-1,441
Closed -$12.8K – 7548
2024
Q4 		$12.8K Buy
1,441
+684
+90% +$15.8K ﹤0.01% 6345
2024
Q3 		$16.3K Buy
+757
New +$15.1K ﹤0.01% 6282
2024
Q2 		– Hold
0
– – – 7288
2024
Q1 		– Hold
0
– – – 7333
2021
Q4 		– Hold
0
– – – 6814
2021
Q3 		– Hold
0
– – – 6651
2021
Q2 		– Hold
0
– – – 6477

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's KZIA Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 2,863 shares worth $41.4K. The stake represents ﹤0.01% of the portfolio and ranks #6499 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in KZIA as recently as Q4 2024.

JP Morgan Chase first reported a position in KZIA in Q3 2024 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • JP Morgan Chase held 2,863 shares of Kazia Therapeutics worth $41.4K as of Q2 2026.
  • Kazia Therapeutics was a new JP Morgan Chase position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6499 holding.
  • JP Morgan Chase first reported a position in Kazia Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.